Tempus AI (TEM) Introduces Loop

Go back to Tempus AI (TEM) Introduces Loop

Tempus Introduces Loop, an AI-Powered Target Discovery and Validation Platform

April 28, 2025 8:30 AM UTC

The new, proprietary target discovery platform integrates RWD, human biological modeling, and CRISPR screens to accelerate novel target identification

CHICAGO--(BUSINESS WIRE)-- Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop, a new oncology-focused platform for target discovery and validation. Loop is Tempus proprietary approach to novel target identification that integrates real-world patient data (RWD) with human-derived biological models and CRISPR-screens, all leveraging AI to rapidly uncover insights for pre-clinical therapeutic development.

One of the biggest... More